Company: RGNX
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001193125-25-268095
Chunk: 0

Company: REGENXBIO Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
REGENXBIO INC.

CONSOLIDATED BALANCE SHEETS

(unaudited)

(in thousands, except per share data)

     September 30, 2025

     December 31, 2024

     Assets

     Current assets

     Cash and cash equivalents
      
     $
     58,802

     $
     57,526

     Marketable securities

     215,403

     177,161

     Accounts receivable

     25,347

     20,473

     Prepaid expenses

     12,943

     9,067

     Other current assets

     19,472

     13,774

     Total current assets

     331,967

     278,001

     Marketable securities

     27,838

     10,179

     Accounts receivable

     2,765

     474

     Property and equipment, net

     107,515

     117,589

     Operating lease right-of-use assets

     48,820

     53,716

     Restricted cash

     2,030

     2,030

     Other assets

     4,268

     4,000

     Total assets
      
     $
     525,203

     $
     465,989

     Liabilities and Stockholders’ Equity

     Current liabilities

     Accounts payable
      
     $
     22,266

     $
     22,798

     Accrued expenses and other current liabilities

     38,316

     38,070

     Deferred revenue

     13,195

     115

     Operating lease liabilities

     9,073

     7,902

     Royalty monetization liabilities

     41,718

     34,309

     Total current liabilities

     124,568

     103,194

     Deferred revenue

     21,186

     —

     Operating lease liabilities

     67,433

     74,131

     Royalty monetization liabilities

     149,916

     25,378

     Other liabilities

     648

     3,635

     Total liabilities

     363,751

     206,338

     Stockholders’ equity

     Preferred stock; $0.0001 par value; 10,000 shares authorized,